Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,200 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by dickie_ho, 03-07-2013, 04:16 PM
|
0 responses
832 views
0 reactions
|
Last Post
by dickie_ho
03-07-2013, 04:16 PM
|
||
|
Started by mutarelli, 03-07-2013, 04:07 AM
|
0 responses
698 views
0 reactions
|
Last Post
by mutarelli
03-07-2013, 04:07 AM
|
||
|
Started by liuliuvet, 03-06-2013, 11:09 AM
|
0 responses
785 views
0 reactions
|
Last Post
by liuliuvet
03-06-2013, 11:09 AM
|
||
|
Started by scondo, 03-06-2013, 03:39 AM
|
0 responses
805 views
0 reactions
|
Last Post
by scondo
03-06-2013, 03:39 AM
|
||
|
Started by NEXT_MACOSX, 03-05-2013, 06:20 AM
|
0 responses
904 views
0 reactions
|
Last Post
by NEXT_MACOSX
03-05-2013, 06:20 AM
|
||
|
Started by mac_user, 03-05-2013, 01:12 AM
|
0 responses
902 views
0 reactions
|
Last Post
by mac_user
03-05-2013, 01:12 AM
|
||
|
Started by db402, 03-04-2013, 08:10 AM
|
0 responses
849 views
0 reactions
|
Last Post
by db402
03-04-2013, 08:10 AM
|
||
|
Started by panza1370, 03-03-2013, 12:47 PM
|
0 responses
820 views
0 reactions
|
Last Post
by panza1370
03-03-2013, 12:47 PM
|
||
|
Started by jenright, 04-09-2012, 04:00 PM
|
1 response
1,273 views
0 reactions
|
Last Post
by panza1370
03-03-2013, 12:42 PM
|
||
|
Started by Tony Reynolds, 03-01-2013, 01:09 AM
|
0 responses
1,492 views
0 reactions
|
Last Post
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 07:41 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
30 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
39 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|